首页 | 本学科首页   官方微博 | 高级检索  
检索        

肠易激综合征大鼠模型的复制与评价
引用本文:杜丽东,吴国泰,刘峰林,景琪,刘五州,任远.肠易激综合征大鼠模型的复制与评价[J].实验动物与比较医学,2014,22(6):43-48.
作者姓名:杜丽东  吴国泰  刘峰林  景琪  刘五州  任远
作者单位:甘肃中医学院, 兰州 730000;甘肃省中药药理与毒理学重点实验室, 兰州 730000;甘肃中医学院, 兰州 730000;甘肃省中药药理与毒理学重点实验室, 兰州 730000;甘肃中医学院, 兰州 730000;甘肃省中药药理与毒理学重点实验室, 兰州 730000;甘肃中医学院, 兰州 730000;甘肃中医学院, 兰州 730000;甘肃中医学院, 兰州 730000;甘肃省中药药理与毒理学重点实验室, 兰州 730000
基金项目:"十二五"国家科技支撑计划项目子课题(No2011BAI05B0206);甘肃省自然科学基金项目(No1212RJZA079);甘肃省中药药理与毒理学重点实验室开放基金项目(NoZDSYS-KJ-2012-004).
摘    要:目的 建立肠易激综合征(IBS)大鼠模型,为实验药理学提供方法.方法 采用复合因素诱导大鼠建立IBS模型,测定模型大鼠体重、摄食量、排便情况、自主运动量、胃排空率和肠推进率,分析血清5-HT、血浆SP、VIP含量以及结肠匀浆5-HT、SP、VIP含量变化,测定血液生化指标,显微观察胃窦黏膜和横结肠黏膜组织形态改变.结果 造模后各大鼠体重减轻、摄食量减少,排便量增多、出现稀便和无定形软便,自主运动量减少,胃排空率减小、肠推进率加快,血清5-HT含量升高、血浆SP和VIP含量均降低,结肠匀浆5-HT和SP、VIP含量升高(P<0.05,P<0.01),血液生化指标未见异常,胃窦黏膜和横结肠黏膜无明显形态改变;匹维溴铵15.0 mg/kg治疗30 d后,大鼠体重、摄食量增加,排便量减少、稀便减少,自主运动量接近正常,血清5-HT含量下降、血浆SP和VIP含量升高,结肠匀浆5-HT和SP、VIP含量下降.结论 复合因素随机刺激能成功复制IBS大鼠模型,其病理生理特征与临床研究结果基本吻合.

关 键 词:肠易激综合征  胃肠功能  5-羟色胺  P物质  血管活性肠肽
收稿时间:2014/6/20 0:00:00

Replication and evaluation of a rat model of irritable bowel syndrome
DU Li-dong,WU Guo-tai,LIU Fen-lin,JING Qi,LIU Wu-zhou and REN Yuan.Replication and evaluation of a rat model of irritable bowel syndrome[J].Laboratory Animal and Comparative Medicine,2014,22(6):43-48.
Authors:DU Li-dong  WU Guo-tai  LIU Fen-lin  JING Qi  LIU Wu-zhou and REN Yuan
Institution:Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu Province Key Laboratory of Pharmacology and Toxicology of Traditional Chinese Medicine, Lanzhou 730000;Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu Province Key Laboratory of Pharmacology and Toxicology of Traditional Chinese Medicine, Lanzhou 730000;Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu Province Key Laboratory of Pharmacology and Toxicology of Traditional Chinese Medicine, Lanzhou 730000;Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China;Gansu Province Key Laboratory of Pharmacology and Toxicology of Traditional Chinese Medicine, Lanzhou 730000
Abstract:Objective The aim of this study was to establish a rat model of irritable bowel syndrome. Methods Thirty healthy adult SD rats (mele:female=1:1) were divided into normal control group, model group, and positive control group (pinaverium bromide tablets 15.0 mg/ kg) for 31 days. Body weight, appetite, defecation, voluntary movement of all the rats were determined. The rates of gastric emptying and small intestinal propulsion rate were measured. The serum 5-HT and plasma SP and VIP or 5-HT, SP, VIP in colon homogenates were assessed by radioimmunoassay. Blood biochemical parameters were measured with an automatic biochemical analyzer. The gastric and intestinal morphology was evaluated by histological examination. Results After modeling, the rat weight and food intake were decreased, ad stool quantity was increased. The voluntary movement and gastric emptying rates were decreased, intestinal propulsion rates were increased, and the contents of SP and VIP in blood were decreased, but increased in the colonic homogenate (P<0.05, P<0.01). After treatment, the food intake was increased and stool quantity was decreased, the rat body weight was significantly increased, the amount of voluntary movement and stool returned near to normal, the 5-HT levels in serum or in colonic homogenate were significantly decreased, but plasma VIP levels were markedly increased, and the SP and VIP contents were significantly decreased in colonic homogenate in the positive control group (P<0.05, P<0.01). Hematology indexes had no obvious changes. The gastric and colonic tissue morphology showed no distinct damages caused by the diverse stimulating factors. Conclusions The stimulation of composite factors can be used to successfully generate the rat model of irritable bowel syndrome, showing similar clinical manifestation of this disease in humans.
Keywords:Irritable bowel syndrome  Gastrointestinal function  5-HT  Substance P (SP)  Vasoactive intestinal peptide
点击此处可从《实验动物与比较医学》浏览原始摘要信息
点击此处可从《实验动物与比较医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号